3543 results for «2129»
3543 results
Clinical outcomes after TAVI: Session 2
29 Nov 2022 – From PCR London Valves 2022
Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!
TAVI in TAVI
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of challenging cases in this session: valve-in-valve in a previous TAVR with healed endocarditis and aortic pseudoaneurysm closure, one-year SAPIEN 3 ultra failure treated with TAV-in-TAV with an Evolut Pro+ system, transcatheter valve implantation and coronary protection in a patient with prior valve-in-valve, and...
Mitral valve-in-valve interventions
Discover various compelling mitral valve-in-valve interventions in this session: bioprosthetic valve dislodgment during transapical valve-in-valve-TMVR, surgical bioprosthetic valve fracture for optimising haemodynamics of mitral valve-in-valve procedure, valve-in-valve TMVR in rheumatic mitral stenosis, and more!
Mitral edge-to-edge repair: surgical and transcatheter approaches - LIVE case
29 Nov 2022 – From PCR London Valves 2022
Learn from these 2 cases of primary mitral repair using percutaneous and surgical approaches:
- LIVE case - A 90-year-old male with history of LAD PCI 23 years ago and paroxysmal atrial fibrillation presents a primary mitral regurgitation (P2 prolapse) on mildly dilated LV and preserved LV function.
The operators...
Transcatheter tricuspid interventions: emerging evidence
29 Nov 2022 – From PCR London Valves 2022
Get insights into the latest studies regarding transcatheter tricuspid interventions with this selection of presentations on TriCLASP, bRIGHT, PASTE, EVALUATE, and more!
Aortic stenosis and concomitant mitral valve disease
29 Nov 2022 – From PCR London Valves 2022
Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.
Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the different needs of mitral and tricuspid patients, to appreciate what optimal medical therapy really means and to improve your knowledge of the anticoagulant requirements for different patient populations.
Optimising immediate and long-term outcomes after TAVI
29 Nov 2022 – From PCR London Valves 2022
This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.
The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems
27 Nov 2022 – From PCR London Valves 2022
In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.
Therapy of valvular heart diseases: a patient-centred innovation journey
27 Nov 2022 – From PCR London Valves 2022
Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.
Reinventing the treatment of patients with tricuspid valve disease
28 Nov 2022 – From PCR London Valves 2022
This innovative session takes you through the patient selection and anatomical characteristics when selecting amongst the different transcatheter options to treat tricuspid regurgitation, followed by a recorded demonstration using the PASCAL Precision repair system.
The new PASCAL Precision system unleashes the full potential of mitral transcatheter edge-to-edge repair
28 Nov 2022 – From PCR London Valves 2022
Join this panel of experienced physicians to learn more about the novel PASCAL Precision system and to discuss implant selection and clinical data. Finally, participate in a recorded case demonstrating the use of the PASCAL Precision system for the treatment of mitral regurgitation.
TAVI-in-TAVI - A road map for successful lifetime management
29 Nov 2022 – From PCR London Valves 2022
Join a team of experts that guide you through the basics of TAVI-in-TAVI, the procedural planning and techniques of implantation, followed by case examples with different index prostheses.
Transcatheter mitral valve replacement - From planning to final assessment
27 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts share their experience with transcatheter mitral valve replacement and more specifically new planning and guidance tools using multiple imaging modalities.
HighLife TSMVR and their latest experiences, moving forward
29 Nov 2022 – From PCR London Valves 2022
A panel of experts review the latest clinical data, study progress and future plans regarding mitral valve replacement, and the position of HighLife, a new technology in this field.
Create the future of TAVI - Optimisation of the procedure and patient pathway
27 Nov 2022 – From PCR London Valves 2022
Dive into this session to discover what can be improved today to be ready to treat future TAVI patient volumes. You'll also learn how to set up a successful TAVI coordinating team and adopt it in your hospital, and how to create a win-win partnership with...
Remaining unmet needs and strategies in TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this session to understand why valve design impacts future patient outcomes and how hemodynamics can impact decision-making and the durability of the TAVI devices. At the end of the session, you'll also get an overview of Medtronic's portfolio.
Technical challenges and optimal device choice for complex TAVI procedures
28 Nov 2022 – From PCR London Valves 2022
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Learn how to anticipate the risks of a valve-in-valve procedure in small surgical prostheses, and discover the latest technological evolutions for treating patients with complex anatomy.
Innovations in TMVR and Intrepid trial updates
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to gain insights on the APOLLO TMVR trial, the Intrepid trial and to hear about future innovations in mitral replacement.
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
